176 related articles for article (PubMed ID: 35067084)
1. Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents.
Malkaram SA; Shatnawi A; Fan J; Carraway H; Denvir J; Primerano DA; Abd Elmageed ZY; Fandy TE
Cancer Control; 2022; 29():10732748221074051. PubMed ID: 35067084
[TBL] [Abstract][Full Text] [Related]
2. Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia.
Carraway HE; Malkaram SA; Cen Y; Shatnawi A; Fan J; Ali HEA; Abd Elmageed ZY; Buttolph T; Denvir J; Primerano DA; Fandy TE
Sci Rep; 2020 Jun; 10(1):10325. PubMed ID: 32587297
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize.
Yang F; Zhang L; Li J; Huang J; Wen R; Ma L; Zhou D; Li L
BMC Plant Biol; 2010 Aug; 10():178. PubMed ID: 20718950
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation.
Si J; Boumber YA; Shu J; Qin T; Ahmed S; He R; Jelinek J; Issa JP
Cancer Res; 2010 Sep; 70(17):6968-77. PubMed ID: 20713525
[TBL] [Abstract][Full Text] [Related]
5. Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia.
Zou Y; Ma X; Huang Y; Hong L; Chiao JW
J Hematol Oncol; 2012 Jul; 5():36. PubMed ID: 22747680
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines.
Zhang C; Suo J; Katayama H; Wei Y; Garcia-Manero G; Hanash S
Clin Proteomics; 2016; 13():14. PubMed ID: 27382363
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
8. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing.
Wu J; Wang SH; Potter D; Liu JC; Smith LT; Wu YZ; Huang TH; Plass C
BMC Genomics; 2007 May; 8():131. PubMed ID: 17524140
[TBL] [Abstract][Full Text] [Related]
9. Digging deep into "dirty" drugs - modulation of the methylation machinery.
Pleyer L; Greil R
Drug Metab Rev; 2015 May; 47(2):252-79. PubMed ID: 25566693
[TBL] [Abstract][Full Text] [Related]
10. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure.
Yan Y; Kluz T; Zhang P; Chen HB; Costa M
Toxicol Appl Pharmacol; 2003 Aug; 190(3):272-7. PubMed ID: 12902198
[TBL] [Abstract][Full Text] [Related]
11. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G
Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991
[TBL] [Abstract][Full Text] [Related]
12. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
Gozzini A; Santini V
Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.
Zhu WG; Lakshmanan RR; Beal MD; Otterson GA
Cancer Res; 2001 Feb; 61(4):1327-33. PubMed ID: 11245429
[TBL] [Abstract][Full Text] [Related]
14. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
[TBL] [Abstract][Full Text] [Related]
15. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of histone H3 and H4 post-translational modifications of esophageal squamous cell carcinoma with different invasive capabilities.
Zhang K; Li L; Zhu M; Wang G; Xie J; Zhao Y; Fan E; Xu L; Li E
J Proteomics; 2015 Jan; 112():180-9. PubMed ID: 25234497
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification.
Fu B; Wang H; Wang J; Barouhas I; Liu W; Shuboy A; Bushinsky DA; Zhou D; Favus MJ
PLoS One; 2013; 8(4):e61423. PubMed ID: 23620751
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
Shaker S; Bernstein M; Momparler LF; Momparler RL
Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
[TBL] [Abstract][Full Text] [Related]
19. Chromatin remodeling in plant cell culture: patterns of DNA methylation and histone H3 and H4 acetylation vary during growth of asynchronous potato cell suspensions.
Law RD; Suttle JC
Plant Physiol Biochem; 2005 Jun; 43(6):527-34. PubMed ID: 15922608
[TBL] [Abstract][Full Text] [Related]
20. [Study on aberration in histone methylation and acetylation in acute leukemia].
Ma XD; Huang YQ; Xiao LY; Zou Y
Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):523-6. PubMed ID: 21122330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
